IntroductIon
The Apc Min/+ mouse is an animal model of human familial adenomatous polyposis [1] [2] . Apc Min/+ mice usually develop numerous adenomas in their intestinal tracts, as a result of loss or mutation of the wildtype Apc allele, and consequently the upregulation of β-catenin [3] .
Apc
Min/+ mice have been frequently used to study the mechanisms underlying the development of colorectal cancer (CRC) and have led to the identification of many factors that either promote or suppress intestinal tumorigenesis. Inflammatory factors are frequently studied for their roles during tumorigenesis in Apc Min mice, and increased inflammation has generally been documented to promote tumorigenesis [4] [5] [6] [7] [8] [9] .
IFN-γ is a pro-inflammatory cytokine that is mainly produced by T cells and natural killer (NK) cells [10] . It has been shown to participate in regulation of antiviral and antitumor immunity [11] . Mouse models deficient in IFN-γ signaling display increased tumor cell proliferation [12] [13] . IFN-γ was reported to selectively induce apoptosis of tumor-initiating label-retaining colon cancer cells [14] . It could alter macrophages from M2 to M1 in Apc Min/+ mouse polyps [15] . However, IFN-γ signaling has also been reported to sequentially activate and inhibit β-catenin, via AKT and DKK1, respectively [16] , which presumably would exert opposing effects on β-cateninmediated tumorigenesis. There were also reports of IFN-γ acting as a pro-tumorigenic factor. For example, transgenic expression of IFN-γ in mouse stomach leads to increased
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inflammation and tumor formation [17] . Development of colorectal carcinomas in Socs1-deficient mice was also found to be dependent on IFN-γ signaling [18] . IFN-γ was recently reported to promote spontaneous papilloma and cutaneous malignant melanoma [19] [20] . Importantly, IFN-γ can induce the production of immunosuppressive PD-L1 in cancer cells, which, through binding to its receptor PD-1 on T cells, may render cancer cells resistant to host immune surveillance [21] . Thus, the role of IFN-γ in tumorigenesis could be context-dependent.
In this study we generated Ifngr1 −/− Apc Min/+ mice and studied the effect of IFN-γ receptor deficiency on the intestinal tumorigenesis. We observed that tumorigenesis is significantly accelerated in the absence of IFN-γ receptor. Gene expression profiling showed that the tumor microenvironment in Ifngr1 
Apc
Min/+ mice ( Figure 1A ). Measurement of hemoglobin levels in those mice indicated that anemia was more severe in Ifngr1 
Min/+ mice ( Figure 1E ). These results suggest that intestinal tumorigenesis is accelerated in Apc Min/+ mice in the absence of IFN-γ receptor. Figure S1) . In a C57BL/6J background, most tumors in the Apc Min/+ mice are benign adenomas and do not exhibit invasion or metastasis [22] . We performed histological examination of the polyps in Ifngr1
IFN-γ receptor deficiency promotes tumor invasion in
−/−
Apc
Min/+ mice and observed that > 30% of them were of invasive nature ( Figure 2C and 2D 
Min/+ mice, in contrast to its absence in tumors of Apc Min/+ mice ( Figure 3D ). It was reported that IFN-γ receptor expression by non-hematopoietic cells is required for tumor immunity and inhibition of angiogenesis [23] . We therefore performed immunohistochemical analysis of CD31, a marker of endothelial cells and angiogenesis, in intestinal 
Min/+ mice were more vascularized. We also surveyed the genes that are differentially expressed between tumors and mucosal tissues by RNA-seq. While 664 genes were upregulated at least 2-fold in tumors when compared to normal mucosa inIfngr1
Min/+ mice (Supplementary Table S4 ), more genes, 939, were upregulated in tumors of Ifngr1 Table S5 ). The upregulated genes were compared to those previously reported to be upregulated in human colorectal cancer specimens when compared to mucosa (GSE20842) [24] . Interestingly, the upregulated genes in tumors of Ifngr1
Min/+ mice were found to be more likely to overlap with those upregulated in human colorectal cancers ( Figure 3F 
Min/+ mice.
Intestinal tumors of Ifngr1

−/−
Apc Min/+ mice exhibit increased inflammation
Because IFN-γ is a pro-inflammatory cytokine, lack of IFN-γ receptor would be expected to bring about changes in the repertoire of cytokines. Gene expression profiling of tumors from Apc Min/+ and Ifngr1 Figure 4A ). Interestingly, many pro-inflammatory factors, such as Cxcl2, Cxcl5 and Cox-2, were upregulated even in non-tumor tissues in the absence of IFN-γ receptor, suggesting that in addition to being favorable for tumor progression, the microenvironment in the intestines of Ifngr1 −/− mice may also be conducive to tumor initiation. We next examined tumor-associated macrophages (TAMs) in intestinal polyps by immunohistochemical staining of F4/80, a marker for macrophages, and found that macrophages were more abundantly infiltrated in tumors of Ifngr1
Min/+ mice than in those of Ifngr1
Min/+ mice ( Figure 4B ).
IFN-γ was reported to promote the phenotypic conversion of TAMs from M2 to M1 in polyps ofApc
Min/+ mice [15] . Expression levels of Cxcl9 and Ccl5, which act downstream of IFN-γ-Stat1 signaling pathway and function as key effector molecules produced by M1 macrophages, were indeed significantly lower in tumors of Ifngr1
Min/+ mice, as revealed RNAseq (Supplementary Table S3 ). In contrast, expression levels of Arginase1, Trem2, and Chil3 (Ym1), which are mice, and the levels of Pcna were evaluated by qRT-PCR (mean ± SD, n = 3 for each group; *P < 0.05, **P < 0.01, ***P < 0.005, Unpaired t test.). Tables S2 and S3 . (b) Validation of representative genes that were shown to be upregulated by RNA-seq. RNA was extracted from intestinal normal tissues and tumors of different groups of mice, and mRNA expression was evaluated by qRT-PCR (mean ± SD, n = 3 for each group; *p < 0.05, **P < 0.01, ***P < 0.005, Unpaired t test.) (c) Validation of representative genes that were shown to be downregulated by RNA-seq. Analysis was performed as in (B) (mean ± SD, n = 3 each; *p < 0.05, **P < 0.01, ***P < 0.005, Unpaired t test. Table S2 ).
The expression levels of representative M1-and M2-associated genes were confirmed by qRT-PCR. ( Figure  4C ). Thus, the impaired IFN-γ signaling due to lack of IFN-γ receptor probably generated a cytokine milieu that favors TAMs toward M-2 polarization.
We Figure S2) . The function of Th1 cells is presumably impaired due to disruption of IFN-γ signaling in Ifngr −/− mice. The expression level of IL-4, which induces Th2 differentiation and also functions as an effector of Th2 cells, was not significantly increased 
Apc
Min/+ mice, and expression levels of the indicated genes were evaluated by qRT-PCR (mean ± SD, n = 3 for each group; *P < 0.05, **P < 0.01, ***P < 0.005, Unpaired t test.). (mean ± SD, n = 3 for each group; *P < 0.05, **P < 0.01, ***P < 0.005, Unpaired t test.). www.impactjournals.com/oncotarget Ifngr −/− Apc Min/+ mice ( Figure 4D) . However, the expression levels of IL-23a and IL-17a, which induces Th17 differentiation and functions as Th17 effector, respectively, were significantly increased in tumors of Ifngr Figure S3) , suggesting that lack of IFN-γ receptor led to increased tumor multiplicity similarly via loss of the wild-type Apc allele.
IFNGR1 was downregulated in human colorectal cancers
Since tumorigenesis in Apc min/+ mice is enhanced in the absence of IFN-γ receptor, we speculated that IFN-γ receptor may function to impede intestinal tumorigenesis and that the intestinal tumors may exhibit a reduced expression of IFN-γ receptor. We first determined the transcript levels of Ifngr1 in adenomas and adjacent normal tissues in Apc Min/+ mice by qRT-PCR. Indeed, Ifngr1 expression was significantly downregulated in tumors when compared to that in mucosa tissues ( Figure 5A ). We next compared the expression levels of IFNGR1 in 65 pairs of human colorectal cancers and normal mucosa tissues (GSE20842) [24] ). Consistently, IFNGR1 was significantly downregulated in cancer specimens when compared to mucosa tissues ( Figure 5B ). It is noteworthy that the single nucleotide polymorphismrs3799488 in IFNGR1 was reported to be associated with increased risk of rectal cancers [26] .
Since IFNGR1 expression was downregulated in human colorectal cancers, we next interrogated whether the expression levels of IFNGR1 were correlated with prognosis of cancer patients using the public available databases GSE14333 and GSE17536. Although no statistically significant correlations between IFNGR1 expression levels and survival were detected, the results suggest a trend that the group with the intermediate levels of IFNGR1 had the longest median survival time ( Figure 5C ). 
Apc
Min/+ mice. In particular, pathways involved in inflammatory response, cell proliferation and tissue remodeling were upregulated with the absence of IFN-γ receptor. Meanwhile, citric acid cycle and oxidative phosphorylation were downregulated, presumably to favor biosynthesis that is in high demand for tumor growth. As expected, cytokine milieu in the intestinal tumors of in Ifngr1
Min/+ mice favored the M2-polarization of TAMs. Consistent with its inhibitory effect on intestinal tumorigenesis, the expression of IFN-γ receptor is commonly downregulated in mouse intestinal adenomas and human colorectal cancers.
Increased tumorigenesis was also reported in IFN-γ
Min/+ mice [27] . Therefore, it appears that deficiency in either the IFN-γ receptor or its ligand would lead to increased intestinal tumorigenesis. While it is clear that IFN-γ signaling functions to impede tumor progression in Apc Min/+ mice, whether the IFN-γ signaling exerts its antitumor effect simply by acting on tumor cells or by modulating tumor microenvironment needs to be clarified. If IFN-γ can inhibit EGFR/Erk1/2 and Wnt/β-catenin signaling pathways, as was reported [27] , lack of IFN-γ receptor would be expected to lead to an upregulation of those pathways in tumor cells, consequently driving the proliferation of tumor cells. It can then be argued that the increased inflammatory response in the tumors of Ifngr1
−/−
Apc
Min/+ mice could be the consequence of accelerated tumorigenesis due to lack of IFN-γ receptor in the tumor cells per se. Our data presented in this study, as well as evidence in some previous studies, implicate IFN-γ signaling as an important player in the regulation of tumor microenvironment. An earlier report showed that expression of IFN-γ receptor on non-hematopoietic host cells, but not that on tumor cells, is essential for antitumor immunity of the host in the effector phase [23] . The facts that IFN-γ-Stat1 signaling is critical for driving M1-polarization of TAMs, and that some proinflammatory factors, such as Ptgs2, and M2-markers are differentially expressed even in normal tissues of Ifngr1 
Min/+ mice was consistent with the previously reported inhibition of MMPs by IFN-γ during inflammation [28] . However, it should be pointed out that while IFN-γ signaling is essential for tumor immunity, excessive activation of IFN-γ signaling pathway may not necessarily lead to better outcomes in patients of colorectal cancer. An examination of possible correlation between IFNGR1 expression levels and survival in colorectal patients revealed no statistically significant association, though tumors with highest and lowest expression of IFNGR1 tend to render patients a shorter survival. A genetic polymorphism in IFNGR1 was reported to be associated with increased risk of rectal cancers [26] , however, whether or not this polymorphism reduces IFN-γ receptor function remains to be determined.
The Ifngr1 
Min/+ mice, enhanced tumorigenesis is not necessarily the major cause of their shorter survival.
Min/+ mice are also impaired in hematopoiesis due to from Apc min/+ mice, and expression levels of Ifngr1 were evaluated by qRT-PCR (*P < 0.05, **P < 0.01, ***P < 0.005, Unpaired t test). (b) IFNGR1 mRNA levels in normal and cancer tissues of colorectal cancers patients were compared. Data were from GSE20842 (*P < 0.05, **P < 0.01, ***P < 0.005, Paired t test). (c) IFNGR1 expression levels and prognosis in human colorectal cancer. Survival information and expression levels of Ifngr1 were obtained from the public available databases (GSE14333 and GSE17536). aberrant activation of Wnt signaling pathway [29] [30] [31] . IFN-γ, on the other hand, also regulates hematopoiesis [32] [33] [34] . It is possible that aberrant hematopoiesis may also contribute to early lethality of Ifngr1 
MAtERIAls ANd MEthods
Mice
The Apc Min/+ mice and Ifngr1 −/− mice in C57BL/6 background were purchased from Jackson Laboratory (Bar Harbor, ME). All the animals were bred and maintained in a specific pathogen-free animal facility. DNA was isolated from tail biopsies as described previously. Genotyping of Ifngr1 −/− mice was conducted following a protocol provided by Jackson Laboratory. The genotypes of the Apc alleles were determined by PCR using the following primers: ApcMin1: 5′-GCCATCCCTTCACGTTAG-3′; ApcMin2: 5′-TTCCACTTTGGCATAAGG-3′; ApcMin3: 5′-TTCTGAGAAAGACAGAAGTTA-3′. Reactions were carried out using a Takara PCR kit(Dalian). Reactions were carried out in cycling condition of 94°C for 3 min, followed by 35 cycles of 94°C for 30 s, 55°C for 1 min, and 72°C for 1 min, followed by 72°C for 5 min. The use and care of the animals were reviewed and approved by the Institutional Animal Care and Use committee at Shandong University School of Medicine.
tumor scoring and tissue preparation
All mice were sacrificed around 18 weeks old. The entire intestinal tract was removed, cut open along its longitudinal axis, and flushed clean with saline. Tumors were counted and measured for the entire length of intestine using a dissecting microscope with a micrometer. All tumors were scored by a single examiner who was blind to the genotype of the subject. Tissues were divided for storage in −80°C and for immediate processing. For histology study, the intestines were fixed flat on slides in 10% buffered formalin for 24 h at room temperature and embedded in paraffin by en face preparation.
Immunohistochemistry
After deparaffinization and rehydration, the sections were boiled in citrate sodium buffer for 15 minutes for antigen recovery, and immersed in 3% H 2 O 2 for 10 minutes to quench endogenous peroxidase. Sections were then blocked with 10% serum at 37°C for 1 hour. The primary antibodies (Ki67 Abcam, 1:200 dilution; Mmp3, Abcam, 1:200 dilution; CD31, Abcam, 1:200; F4/80, Proteintech, 1:200 dilution) were added to the sections and incubated overnight at 4°C. After washing, the sections were coated with a horseradish peroxidase (HRP) conjugated second antibody (Jackson ImmunoResearch; 1:200 dilution) and then incubated at 37°C for 1 hour. DAB was used to visualize immunoreactions [35] .
RNA sequencing
Tumor samples in each group were pooled and were subjected to RNA extraction. Sequencing libraries were generated using NEBNext ® Ultra ™ RNA Library Prep Kit for Illumina ® (NEB, USA) following manufacturer's recommendations. Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Fragmentation was carried out using divalent cations under elevated temperature in NEBNext First Strand Synthesis Reaction Buffer. First strand cDNA was synthesized using random hexamer primer and M-MuLV Reverse Transcriptase. Second strand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. Remaining overhangs were converted into blunt ends via exonuclease/polymerase activities. PCR was performed with Phusion High-Fidelity DNA polymerase, Universal PCR primers and Index (X) Primer. PCR products were purified (AMPure XP system) and library quality was assessed on the Agilent Bioanalyzer 2100 system. The clustering of the index-coded samples was performed on a cBot Cluster Generation System using TruSeq PE Cluster Kit v3-cBot-HS (Illumina) according to the manufacturer's instructions. After cluster generation, the library preparations were sequenced on an Illumina Hiseq 2000/2500 platform and 100 bp/50 bp single-end reads were generated.
Quantitative Rt-PCR
Total RNA was extracted from frozen tissues or cultured cells using TRIzol reagent (Invitrogen), and was reverse transcribed using reverse transcriptase (TOYOBO). Quantitative real-time PCR analysis was performed on a Roche LightCycler ® 480 System using SYBR GREEN mix (TOYOBO). Primers used for quantitative RT-PCR were listed in the supplementary Table S1 . www.impactjournals.com/oncotarget loh analysis of Apc Tumor or normal tissue was excised carefully and DNA extracted. Loss of heterozygosity (LOH) at Apc locus was determined by PCR, as described for genotyping of the mouse tails.
statistical methods
Data analysis was performed using the Mantel-Cox test or 2-tailed student's t-test (SPSS 11.5 software, SPSS Inc., Chicago, IL). All data were expressed as the mean ± SD, and significant outcomes were shown as follows: *P < 0.05, **P < 0.01, and ***P < 0.005.
